Good Manufacturing Practice (GMP)
GMP is generally defined as ‘that part of QA, which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization’ (European GMP guidelines; WHO guidelines).
From this definition, there are a number of points that should be emphasized:
• GMP is part of QA. In other words, it is a preventative operation that is designed to make sure things happen in the correct manner. This means that, unlike QC, the quality of any operation can be affected by the GMP measures that are put in place.
• There is a requirement for consistency. It is no good producing a batch of product correctly one day, if there is no guarantee that the same result cannot be obtained every day.
• GMP relates specifically to the manufacturing aspects of a product pipeline. This is defined as the point from which starting materials are purchased from approved suppliers to the point where finished product leaves the factory. Indeed, there is also a responsibility to ensure the quality of the product during distribution, even though at this point it is often outside the control of the manufacturer.
• Quality standards should be appropriate to the intended use of the product. Hence the requirements to be fulfilled for the manufacture of an aseptically filled injection will be far more stringent than those for the manufacture of a multivitamin tablet.
• The standards are previously defined in the application for marketing authorization. Hence there is a clearly defined process by which each product must be manufactured.
Responsibilities under GMP
-There are ten elements in total, and these are described as follows:
•
•
•
•
•
•
•
GMP is generally defined as ‘that part of QA, which ensures that products are consistently produced and controlled to the quality standards appropriate to their intended use and as required by the marketing authorization’ (European GMP guidelines; WHO guidelines).
From this definition, there are a number of points that should be emphasized:
• GMP is part of QA. In other words, it is a preventative operation that is designed to make sure things happen in the correct manner. This means that, unlike QC, the quality of any operation can be affected by the GMP measures that are put in place.
• There is a requirement for consistency. It is no good producing a batch of product correctly one day, if there is no guarantee that the same result cannot be obtained every day.
• GMP relates specifically to the manufacturing aspects of a product pipeline. This is defined as the point from which starting materials are purchased from approved suppliers to the point where finished product leaves the factory. Indeed, there is also a responsibility to ensure the quality of the product during distribution, even though at this point it is often outside the control of the manufacturer.
• Quality standards should be appropriate to the intended use of the product. Hence the requirements to be fulfilled for the manufacture of an aseptically filled injection will be far more stringent than those for the manufacture of a multivitamin tablet.
• The standards are previously defined in the application for marketing authorization. Hence there is a clearly defined process by which each product must be manufactured.
Responsibilities under GMP
-There are ten elements in total, and these are described as follows:
•
Defined processes:
all manufacturing processes should be clearly defined during development and reviewed on an ongoing basis to ensure that they are appropriate and capable of consistently producing the required result.•
Validated processes:
all critical steps within a manufacturing process should be validated when the product/process is first introduced and whenever there are any substantive changes made to that process. This ensures that the process not only performs consistently but also can be proved, with documented evidence, to do so.•
Necessary facilities:
it is important that all the appropriate facilities are in place. In this context, facilities is defined in its widest sense as trained, qualified personnel; sufficient, suitable premises; appropriate equipment and services; materials, correctly labelled in appropriate containers; standard operating procedures, and other documenta- tion such as batch manufacturing records and batch packaging records; and appropriate arrangements for storage and transport.•
Clear documentation:
manufacturing instructions and standards operating procedures should be clearly written in a manner that will be understood by the personnel for whom they are intended. They must be tailored to the specific facility in question.•
Trained operators:
even with defined processes and clear documentation, manufactur- ing will not be carried out satisfactorily unless the operators are properly trained in all the necessary procedures.•
Appropriate records:
all activities taking place during the manufacturing must be adequately recorded – if it is not written down, it did not happen. This documentation may be completed manually, or by electrical or electronic recording devices. In many companies, there is a mixture of both. However, in either case, there must be an effective control system for obtaining and maintaining these records. All process deviations must also be recorded and fully investigated before a batch can be released.•
Batch traceability:
it is important that all manufacturing records are maintained in a suitable format so that full traceability is available. This particularly includes distribution records, which are critical in the case of a batch recall.•
•
•
Quality maintained during distribution:
the responsibility for maintenance of quality does not end at the factory gate. It is important that throughout the distribution chain, appropriate controls and storage conditions are maintained. This is reasonably easy when the manufacturer controls the distribution channel. However, even when the products are distributed by other entities (such as wholesalers), there is still a responsibility to ensure that they are aware of and understand the importance of all such requirements.•
Recall system:
whilst no company wants to have to deal with a recall situation, it is necessary for all companies to be prepared for this eventuality. A procedure must be in place, which has been tested in a ‘dry run’ to ensure that it will operate effectively.•
Complaints system:
all complaints must be investigated to determine whether they are justified or not. If they are justified, it is necessary to determine whether this is a one- off occurrence or part of a trend. Actions must be put in place to rectify any immediate problems and prevent any recurrence.Batch packaging records
The batch packaging record is required for every batch or part batch that is packaged. It is developed from the relevant part of the packaging instructions and, once again, its review is an important part of the batch release process. Depending on company practice and the design of the document, it may be specific to a particular batch size or may be used for a variety.
Comments made previously regarding area clearance checks also apply here. Use of a checklist for these checks is very helpful. Looking under tables and checking for extra labels or primary containers are very important.
The information required for the completed batch packaging record will once again consist of a combination of pre-printed material and data that are added by the operators during the process.
If returns to the stores are permitted for printed packaging materials, they should first be checked to make sure that they have not been batch coded. A QC signature is required as part of this process, either on leaving the packing hall or being received in the stores.
If excess materials are destroyed, there must be a record of the quantities on the batch documentation. There should also be a procedure covering destruction, including methods and responsibilities.
Reconciliation is of vital importance, since it helps to confirm that the batch has been processed correctly. Any significant variation in materials should be taken as an indication that there could be a problem and must be investigated before the batch is released.
The batch packaging record is required for every batch or part batch that is packaged. It is developed from the relevant part of the packaging instructions and, once again, its review is an important part of the batch release process. Depending on company practice and the design of the document, it may be specific to a particular batch size or may be used for a variety.
Comments made previously regarding area clearance checks also apply here. Use of a checklist for these checks is very helpful. Looking under tables and checking for extra labels or primary containers are very important.
The information required for the completed batch packaging record will once again consist of a combination of pre-printed material and data that are added by the operators during the process.
If returns to the stores are permitted for printed packaging materials, they should first be checked to make sure that they have not been batch coded. A QC signature is required as part of this process, either on leaving the packing hall or being received in the stores.
If excess materials are destroyed, there must be a record of the quantities on the batch documentation. There should also be a procedure covering destruction, including methods and responsibilities.
Reconciliation is of vital importance, since it helps to confirm that the batch has been processed correctly. Any significant variation in materials should be taken as an indication that there could be a problem and must be investigated before the batch is released.
Pineal Gland
Synthesizes melatonin, which – because of its position in the third ventricle – is secreted directly into the cerebrospinal fluid (CSF), from where it finally ends up in the blood. Melatonin affects reproductive development and daily physiology.
Synthesizes melatonin, which – because of its position in the third ventricle – is secreted directly into the cerebrospinal fluid (CSF), from where it finally ends up in the blood. Melatonin affects reproductive development and daily physiology.
Which of the following is correct Avogadro’s number?
Anonymous Poll
26%
6.02x10^23
24%
6.22x10^24
45%
6.23x10^23
5%
6.32x10^24
GPAT MCQs
Which of the following is correct Avogadro’s number?
MCQ No. 1973 | Pharmaceutical Chemistry
MCQ No. 1974 | IMA
In Electron capture detector, the electrode is treated with
In Electron capture detector, the electrode is treated with
Anonymous Quiz
8%
Radio isotope
10%
Active isotope
33%
Radioactive isotope
50%
All of the above
MCQ No. 1975 | Pharmacology
In case of drugs, like morphine they are injected by using
In case of drugs, like morphine they are injected by using
Anonymous Quiz
28%
Albumin
15%
Bilirubin
24%
Bile pigments
32%
Adipose tissue
The protein synthesis inhibitors act by disrupting the bacterial 70S ribosomal mRNA complex that is responsible for bacterial protein synthesis. Since eukaryotes utilize a different ribosomal complex (80S), these drugs do not interfere with human cellular protein synthesis. The bacterial 70S ribosomal complex is composed of two subunits (30S and 50S), and the protein synthesis inhibitors act at one of these subunits.
MCQ No. 1976 | Pharmacology
Which of the following antibacterial agent is a 30S inhibitor?
Which of the following antibacterial agent is a 30S inhibitor?
Anonymous Quiz
8%
Linezolid
24%
Clindamycin
55%
Tetracyclines
13%
Chloramphenicol
The nucleoside (NRTIs), nucleotide, and nonnucleoside (NNRTIs) reverse transcriptase inhibitors (RT inhibitors) all inhibit the formation of viral DNA from RNA by reverse transcriptase.
The protease inhibitors interfere with processing of the viral protein, thus preventing formation of new viral particles.
Enfuvirtide blocks the fusion of the viral particle to the target cell, while maraviroc inhibits entry of the viral particles into cells.
Therapy for HIV is either based on inhibition of RT using one NNRTI + two NRTIs or based on use of a protease inhibitor using one or two PIs + two NRTIs.
Today’s live Q&A session will start at 7:30pm
Those who have any questions regarding GPAT preparation can join the live session and ask your questions.
Host: Mr.Suraj Kause.
GPAT 288 (AIR)
NIPER 998 (AIR)
Those who have any questions regarding GPAT preparation can join the live session and ask your questions.
MCQ No.1977 | IMA
In Flame emission photometers, the measurement of _____________ is used for quantitative analysis.
In Flame emission photometers, the measurement of _____________ is used for quantitative analysis.
Anonymous Quiz
23%
Colour
57%
Intensity
11%
Velocity
9%
Frequency
Today’s live Q&A session will start at 07:00pm
- Those who have any questions regarding GPAT preparation or any other kind of questions can send their questions on https://t.me/KTAsupport.
- While sending your questions to this account please mention your full name and college name which you belong from.
- We will discuss this question in live session.
Host: Mr.Suraj Kause.
GPAT 288 (AIR)
NIPER 998 (AIR)
- Those who have any questions regarding GPAT preparation or any other kind of questions can send their questions on https://t.me/KTAsupport.
- While sending your questions to this account please mention your full name and college name which you belong from.
- We will discuss this question in live session.
We are starting live Q&A session. please join fast. session will last for 1hr and those who misbehave during live session will be permanently banned from our channel.